Market-Leading Transcatheter Aortic Valve Delivers Positive Clinical Outcomes Through Two Years in Major International Study; Achieves 10,000-patient Milestone PARIS--(BUSINESS WIRE)-- New clinical ...
MINNEAPOLIS - Medtronic, Inc. today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic ...
MINNEAPOLIS - Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve System for patients with severe aortic stenosis who are ...
Medtronic ($MDT) scored a pivotal CE mark that will help expand the market for its CoreValve transcatheter aortic valve replacement (TAVR). This latest regulatory nod ...
Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for its 31mm Medtronic CoreValve® System, the only transcatheter aortic valve ...
Patients implanted with the CoreValve transcatheter aortic valve replacement showed strong blood flow and improved quality of life at five years post-implant, according to results from two Medtronic ...
Medtronic says it plans to appeal the $73.5 million jury verdict that its CoreValve transcatheter aortic valve system infringes a U.S. Andersen patent owned by Edwards Lifesciences. The CoreValve ...
The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s CoreValve Transcatheter for use without undergoing an independent device advisory panel review for the product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback